ABSTRACT. Cultured fibroblasts from 13 patients with organic aciduria suggesting 3-oxothiolase deficiency were studied by measuring first the capacity of the isoleucine degradative pathways in whole cells, as the incorporation of 1-[I4C]-2-methylbutanoicacid into macromolecules, and, second, the activity of 3-oxothiolase in cell homogenates using specific 3-oxoacyl-CoA substrates to identify the different enzymes. Nine patient s showed low incorporation by the macromolecular labeling assa y, as well as deficiency of 2-methylacetoacetyl-CoA thiolase. In this group of patients, low activity by the macromolecular labeling assay was associated with clinically severe symptoms, and vice versa. Two patient s showed reduced macromolecular labeling, but apparently normal 3-oxothiolase. Finally, two patients showed normal acti vities by either test , the reason for their particular organic aciduria being unknown. In conclusion, occurrence of urinary 2-methyl-3-hydroxybutyric acid and/or tiglylglycine is not an unequivocal indicator of the absence of the thiolas e that metabolizes 2-methylacetoacetyl-CoA. Measurement of I-p4C]-2-methylbutanoic acid incorporation in cultured fibroblasts adds important information in stud ying possible defects of the isoleucine catabolic pathway. (Pediatr Res 28: 518-522, 1990) by Daum et al. ( I) , Since then , a number of cases have been reported, with a somewhat varying patt ern of organic aciduria, but genera lly excretion of 2-methyl-3-hydroxybutyric acid and tiglylglycine (2-15 ). In some of these cases, a defect in th e mit ochondrial short chain-length-specific thiolase (EC 2.3.1.9) (McKusick 20375) has been observed (7,9-12). Clinically, the patient s show a highly variable symptomatology, some cases presenting in the 1st year of life with severe ketoacidosis and lifethreaten ing disease, other cases present ing with mild attacks with lethargy and vomiting later in childhood. We are thu s faced with a syndrome of highly variable clinical severity, as well as biochemical heterogeneity with a varying degree of organ ic aciduria. To clarify this situation, we developed an MMLA that measure s the overall capacity of isoleucine degradation distal to 2-methylbutyryl-CoA, using [1-14 C]-2-methylbutan oic acid incorporation in cultured fibroblasts from skin biopsies. In parallel, we measured the fibroblast activities of 3-oxothiolase using 2-methylacetoacetyl-CoA as well as acetoacetyl-CoA and 3-oxohexano yl-CoA to give positive identification of an y decreased activities of the different cellular th iolases present. Som e of the results have been briefly reported elsewhere ( 16, 17) .
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MATE RIALS AND MET HODS
An inborn error of isoleucine catabolism (Fig. I) characterized by urina ry excretion of 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, tiglylglycine, and butanone was first described Dulbecco's MEM, nonessent ial amino acids, L-glutamine, penicillin, streptomycin, trypsin, and NCS were obtained from R ow Laboratories (Herts, England ).
Sec-butylmagnesium chloride (catalog 22, 442-1, 100 mL ), flex needle (catalog Z 10, 091-9), round bottom storage flask with Teflon stopcock (500 mL, catalog Z IO, 223-7, standard taper joint 24/40), septa (catalog Z12, 440-0), and nonradiolabeled 2-methylbutanoic acid (D,L) were purchased from Aldrich Chemical Co. (Milwaukee, WI). Carbon dioxide C 4 C, I mCi, sp act 55.9 mCi/mm ol) in a breakseal tu be was obtaine d from ICN Radiochemicals (Irvine, CA). Silicic acid was obtained from Sigma Chemical Co. (St. Louis, MO). 2-Methylbutan-2-o1 and chloroform were obtained from America n Burdick Jackson (Muskegon, MI). Th e omni glass colum n used for liquid partition analyses had the dime nsions of 6.6 mm inner diameter x 250 mm (Rainin Instruments, Emeryville, CA). L- [4,5- 3H]l ysine (sp act 98 Ci/ rnmol) was obtained from the Radioch em ical Centre (Amersham, UK).
Synthesis of [1-1 4Cj-2-methylbutanoic acid.
[l-14C)-2-methylbutanoi c acid was synth esized via th e G rignard reagent and [14C) CO2 ( 18) . The 500-mL round-bott om storage flask was dried overnight in an oven at 140°C after removal of the Teflon 5 18 Abbreviations M ML A, macromolecular labeling assay GCMS, gas chromatography mass spectrometry M EM, minimal essential medium NCS, newborn calf serum sponding to mass effects from C l4 versus C 12. For the determination of sp act, the ratios of C14/C12 at m/z 74, 76, 87, and 89 were determined from the reconstructed ion current for three separate injections of the synthesized [l-' 4C]-2-methylbutanoic acid. With this procedur e, we found an average of 82.4% of the theoretical sp act of our [l-14C]-2-meth ylbutanoic acid, yielding a final sp act of 46.1 mCi/mmoI. This value probably reflects a small amount of Cl2 in the nitrogen used in the Grignard reaction.
Patients and cells. Patients studied were those who had one or more abnorma l elevations of 2-meth yl-3-hydroxybutyric acid, 2-methylacetoacetic acid, or tiglylglycinein urine, either in random specimens or after a challenge with isoleucine. This pattern of urinary organic acids is generally considered to be indicative of a deficiency of 3-oxothiolase, provided that oth er metabolites characteristic of prop ionic or meth ylmaloni c acidemia are not elevated (23) . Fibroblasts derived from 13 patients were provided by a large group of investigators (see Acknowledgments). A brief summary of the major clinical characteristics of the patients is presented in Table I with literature references to the reported cases. Th e following brief case reports describe those not previously reported.
Case M .T. This patient is a sister ofC.T. (7) . The parents were nonconsanguineous and of French-Canadian heritage. She presented at 9 mo of age with an infection-provoked episode of severe ketoacidosis. Urin e GCMS revealed 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetate, and tiglylglycine. The initial crisis episode was treat ed with high-dose i.v. glucose. She has required several hospitalizations for treatment with i.v. glucose, but has developed normally. Case s.s. Thi s female patient (U.S., white) presented with vomiting, poor feeding, ketoacidosis, and lactic acidosis at 3 mo of age. During the first 8 h after an isoleucine load, urinary 2-methyl-3-hydroxybutyrate was 23 mmol /rnol creatinine and tiglylglycine 8 mmol /rnol creatinine, suggesting the possibility of 3-oxothiolase deficiency ( I I). Subsequently, she had an extremely complicated history with epileptic seizures, mild optic nerve degeneration, insulin-dependent diabetes, and hypertrophi c cardiomyopath y with supraventricular tachycardia. She died at the age of 2 y. Autopsy suggested subacute necrotizing encephalomyelopathy. stopcock. An 18 (length) x 0.5 (width) cm glass rod was similarly dried. After cooling, the rod was inserted throu gh a small needle hole in the center of a 24-mm septum. A magnetic stirbar and the ampoule of [14C]C0 2 (with breakseal closure facing upward ) were placed in the round-bottom flask and the septum with rod inserted was wired in place on the round-bottom flask with two turns of copper wire. The rod was then positioned 1-2 inches above the breakseal closure. The Teflon stopcock was opened and the entire system flushed with dry nitrogen gas. Nitrogen flow was halted and the stopcock closed. Approximately 2 mL (4 mmol ) of sec-butylmagnesium chloride in ether were introdu ced through the septum by the double-tipped needle transfer procedure as previously described (19) . Magnetic stirring was in itiated and the breakseal closure shattered by plunging the rod downward . Reaction was carried out at room temperature for 24 h. After this period, 0.5 mL of aque ous 1 N NaOH was injected through the septum and stirred for 1 min , and the reaction vessel opened to the atmosphere to destroy excess Grignard . The reaction vessel was rinsed with three lO-mL aliquots of water, the pH of the rinses adjusted to 7 with 1 N NaOH , and the rinses lyophilized to dryness. The lyophilized fractions were taken to a pH below 1 with 5 N H 2S04 and a small piece of dry ice added to each fraction to remove excess radiolabeled CO 2 gas. The fractions were then adsorbed onto silicic acid that had been previously rinsed for 2 h with 9% 2-methylbutan-2-01in chloroform (20) . The column was packed with the silicic acid and the (22) . The Cl8 HPLC column was previously standardized by analysis of 50 }Lmol of standard 2-methylbutanoic acid in absolute ethanol and monitoring of I-min collected fractions at 212 nm in a Gilford recording spectrophotometer. The column flow rate was 1.45 mL/min. The column was equilibrated and eluted for 30 min with 0.05 M potassium phosphate buffer, pH 2. 1 (buffer A), followed by elution with 85% A/15 % methanol for the next 20 min , after which the column was returned to the starting conditions by elution with A for 30 min. Using this system, standard 2-methylbutanoic acid eluted at 42 min. For analysis of radiochemical purity, 1 }LCi of [l-14C]-2-meth ylbutanoic acid was applied to the column. Greater than 97% of the dpm eluted at the expected retention time for 2-meth ylbutanoic acid. For the determination of sp act, measurements were carried out on a DB-Wax polyethylene glycol gas chromatograph capillary col- Case B.M. T his case is described in detail elsewhere (24) . An isoleucine challenge was given because the patie nt 's twin br ot her had slightl y elevated 2-me thyl-3-hydroxy butyrate. In th e first 8-h urine after isoleucine challenge, 8 .M. had 2-methyl-3-hydroxybuty rate of 89 rnm ol/ rnol creatini ne and tiglylglycine of 10 mrnol/rnol creatinine, suggesting 3-oxo thiolase defic ienc y ( I I).
Case Z iE, T his case is described in detai l elsewhere (24) . Th e patient was found by organic acid ana lysis to excrete 2-me thyl-3-hydroxybutyrate at 8 mmol/rnol creatini ne and tiglylglycine at 68 mmol /mol creatinine, without an isoleucine challenge, suggesti ng the possibi lity of a deficien cy of 3-oxothio lase ( I I).
MMLA . Fibroblasts from health y individuals were used as co ntrols. The cells were grown in D ulbecco's M EM supplem ented with 10% NCS , penicillin , and stre pto m ycin. H arvesting was do ne using 0.25 % trypsin-EDTA. The labeling assay was derived from the method described by Willard et af. (25) , in which abnormalities of prop ionate metabolism were studied by incubation with [1-14C] prop ion ic acid and by determining the incorpora tion of rad ioactivity int o acid -precipitable prot eins. Simil ar methods with 14C-isoval er ic acid have been report ed (26) (27) (28) . Fibroblasts were grown to approxi mately 90 % co nfluenc y in MEM -NCS. The med ium was rem oved and the cells were washed in Puck's salin e F and incubated at 37"C for 20 h in Puck's saline F with the following final concentration s: 15% NCS, 5 mmol /L glucose, an d 3.9 JLmol/L [1-'4C]-2-meth ylbu tanoic acid (180 JLCijL). After incubation, the medium was removed and the cells rin sed and har vested with try psin .
After sto pping the reaction of trypsin by the add ition of MEM-NC S, th e cell suspe nsions were transferred to 15-mL tu bes and cen trifuged for 5 min ( 1500 rpm) at 20°e. Th e cell pelle t was extracted with cold 5% trichloroacetic acid, left for 10 min at 4°C, and centrifuged for 5 mi n at 400 0 rpm . T he preci pitate was d issolved in I N NaOH . Aliq uots were taken for liqu id scintillat ion counting and determinati on of protein (29) .
Enzym e analysis. Fibroblast extra cts containi ng 10-50 JLg p rotein were assayed in dupl icate for pro tein , citrate synthase, and thi olase activity as describ ed prev ious ly ( 10) . T hiolase activity was deter mi ned with three substrates: acetoacetyl-CoA (C ), 2-methy lacetoac etyl-CoA (C e), and 3-oxo hexanoyl-CoA (C 6 ) . T he latt er substrate (C6) measures the wide specificity th iolase (EC 2.3. 1.16) of mitochondria and peroxisomes. Cs substrat e measures the mitochondrial th iolase (EC 2.3 .1.9), the absence of which ca uses 2-methyl-3-hyd roxybut yric aciduria (Mc K usick 20375). The C4 substra te is the co m mo n substrate for all the th iolases (cyt oplasmic and m itochondrial EC 2.3. 1.9, and m itocho ndrial EC 2.3. 1. 16) and is therefore not discriminatory. However, experience has shown that the activity rat io Cs/ C is the most reliable detector of heterozygotes for th is disord er (30) . T he detection lim it of the thiolase assay is approximately 0. 1 nmol. When very low or zero activities were enco untere d , the assay was repeated 1) with four times the original amount of protein to detect any significant activity and 2) with four times the sta ndard assay concentration of 2-methylacetoacetyl-CoA or CoASH to ensure th at a K m defect was not responsib le.
RESULTS

Mac rom olecular labeling with [1-14Cj-2-methylbutan oic acid.
T he incorp oration of 14C from 2-me thylbutanoic acid into macromolecules is presented in Table 2 . Fibroblasts from healthy subjects (n = 6) show ed a mean incorp oration of 2.64 pmolh-I . mg" of protein, the range being 1.83-3.65. This incorporation is about 10 times less th an the inco rp oratio n from 14e-isoval eric acid int o macromolecules thro ugh the leucine pathway, but the relative SD are similar, being 24% for the former and 28% for the latter (28) . When study ing the incorporation in fibrob lasts from 13 pati ents with 2-me thyl-3-hyd roxybutyric aciduria, two patients showed incorporation within the normal range (1.99-2.97 pm ol -h-I . mg'" ), whereas in II cases, th e incorporatio n was clearl y reduced and ra nged fro m 0.05 to 1.06 pmol -hJ -mg" , correspo nding to 2-4 1% of the mean no rmal value .
T he possibility was co nsidered that a vary ing rate of protein synthesis by the mu tant cells might in flue nce the degree of macromolecular labeling by [1-14C]-2-m ethylbutanoic acid . Th erefore, in separate experiments, we mo nito red th e rate of protein synthesis by the inco rpo ration of3H-lysine. In six mutant cell lin es with ma cromolecular labeling rangi ng from 2-32% of nor mal, th e lab elin g of prote in by 3H-Iysine sho wed a relative SD of 26.5% , and there was no co rrelati on between the labelin g of pro tei n by 3H-Iysine and [1-14C]-2-m eth ylbutan oic acid.
3-0xothiolase activities in broken cells. When th iolase act ivity was measured with three differe nt substrates (C 4, C s , and C 6 , see Materials and Methods), the activity ratio C S/C4 has been sho wn to be the most reliable parameter in distinguishing patient s, heterozygotes, and normals for McK usick 20375 (30). The C s / C4 ratio in fibroblasts from 15 co ntrols was 1.18 ± 0. 18 (me an ± SD). When measu ring the enzyme in fibroblasts fro m 13 3-0XOT HIOLASE DEFICIENCY 52 1 patients with suspected 3-oxothiolase deficiency, activity with C, substrate (and the Cs/C ratio) was undetectable in eight patients.
In patien t L.V., th e C S/C4 ratio was very low and variable, ranging from 0.13 to 0.33. The remaining four patients showed normal ratios ranging from 0.96 to 1.30. The mean Cs/C ratio in fibroblasts from 10 heterozygotes was 0.51. In no case was there evidence of abnormally high Km for C, substrate. Also, no fibroblast extract from patients showed significant abnormality in thiolase activity with C 6 substrate, and all gave activities of citrate synthase within the normal range (data not shown).
Ma cromolecular labeling versus enzyme activities. When combining MMLA and enzyme activities from the different patients, a cert ain pattern emerged (Table 2) . Ni ne pat ients showed deficient 3-oxothiolase as well as reduced activit y by MMLA. Two patients exhibi ted clearly reduced acti vity by MMLA, but normal or near normal activities of 3-oxothiolase. Finally, two patients showed normal act ivities by either test.
DISCUSSION
The patients with suspected 3-oxothiolase deficiency that we stu died clearly fall into three categories: 1 ) patients with low incorporatio n by the MMLA and also low or unde tectab le 3-oxothiolase acti vity toward 2-methylacetoacetyl-CoA ; 2 ) patients with low activity by MMLA, but normal enzyme acti vities; and 3 ) patients with normal MMLA as well as normal enzyme activities.
The pati ents in the first category (n = 9) clearly suffer from mitochondrial 3-oxothiolase deficienc y that is manifest by enzyme measurements in broken cells, as well as in whole cells in vitro, as demonstrated by MMLA. Ho wever, although this group of patients with one excepti on showed no det ectable enz yme activity, they presented a strik ing clinical heterogeneity. To some extent, th e degree of clini cal severity was reflected by M MLA. Thus, severe clinical symptoms were generally encountered in pati ents with less than 20 % of normal acti vity by MMLA. Patient M.A.I.P., on the other hand, being a symptom-free sibling of the affected patient A.I.P., showed 31 % of normal MMLA acti vity. Furthermore, patient L.V ., with 32% of normal MMLA activity, remained well between episodes of keto acidosi s and showed normal growt h and develo pment. In this case, an isoleucine load was initially necessary to clarify the picture. Work is in pro gress to study the possibility of genetic heterogeneity within this group of pa tients.
The second group of pati ents (n = 2) raises extremely interesting questions. These patients had deficient isoleu cine catabolism as measured by MMLA and abnormal profiles of organic aciduria, but enzyme mea surement apparently excluded 3-oxothiolase deficiency . In pa rticular, the norm al thiolase activity in W.G. 88 cells was quite unexpected. These cells were from th e original proband J.B., who led Da um et at. (1, 3) to suggest that the absen ce ofthiolase activity was the cause of the symptoms. These authors showed that W.G. 88 cells metabolized isoleucine at only 44-46% of normal rate. In the early studies, J.B. did no t have elevated tiglylglycine , but , interestingly, re-examination of this patient at age 28 revealed large am ounts of tiglylglycine (Scriver CS, personal communication). W.G.138 cells, also originally stud ied by Da u m et at. (3) , clearly have abnormal thiolase activity. The mu tant allele may therefore be different in th e cell lines W.G . 88 and W.G . 138, as originally suggested (3).
In Z.M ., the other patient in our cate gory 2, there was intermittent excretion of tiglylglycine . We attempted to determine whether the 2-meth yl-3-hydroxybutyryl CoA dehydrogenase was deficient. Cell lysates were incubated with tiglyl-CoA, tritiated water, NAD, and avidin (5) . The incorporation of label into propionate was normal , suggesting normal dehydrogenase. Patient Z.M. therefore seems to have a previously unexplained inhibition of the isoleucine pathway in intact cells. A possible explanation might lie in a functional defect at the thiolase step caused by the accumulation of an inhibitory metabolite due to a primary lesion somewhere else in the pathway of isoleucine catabolism. In any case, the occurrence of urinary 2-methyl-3-hydroxybutyric acid and/or tiglylglycine is not an unequivo cal indicator of the absence of the thiolase that metabolizes 2-methylacetoacetyl-CoA.
The patients in the 3rd category (n = 2) apparentl y have no disorder of isoleucine catabolism distal to 2-methylbutyryl-CoA, and the reason for their particular pattern of organic aciduria is unknown.
Note added in proof:
Since the submission of this paper we have had the opportunity to examine another fibroblast explant 
